Christina is a science writer for the American Society for Cell Biology. She earned her Ph.D. in Cell Biology and Molecular Physiology at the University of Pittsburgh.
Is there life after graduate school? For doctoral students and postdocs who've been wondering what their future lab life could be like outside academia, say in the biotech industry, here's a chance to get a taste and some intensive training in a free-to-the-student 12-day MBA-style, case-based course. ASCB and the Keck Graduate Institute (KGI), with generous funding from EMD Millipore, have teamed up to offer "Managing Science in the Biotech Industry: An Intensive Course for Students and Postdocs" to 40 postdocs and graduate ASCB members this June in Claremont, CA.
Elaine Fuchs grew up surrounded by scientists. Her father and aunt were scientists at Argonne National Laboratories, and later her older sister became a neuroscientist. So Fuchs has followed in the family footsteps. Today she is a Howard Hughes Medical Institute investigator, a professor at the Rockefeller University, and a widely recognized pioneer in adult stem cell research. She is also a former ASCB President. As an ASCB stalwart and a stem cell pathfinder, Fuchs was drafted to serve on the ASCB Stem Cell Task Force last spring and helped write the preliminary report, which was presented for public comment last month.
Tina Han, postdoctoral fellow at the University of California, San Francisco (UCSF), found out that she'd just won $5,000 on Facebook. It wasn't a holiday giveaway or a scam. It was a missed voice mail from ASCB and a friend's quick Facebook message that Han was the winner of ASCB's $5,000 Kaluza Prize supported by Beckman Coulter for outstanding research as a graduate student.
You finished all your replicates, your data are entered into your favorite statistical software, and you've got your fingers crossed that the test reveals a P-value of less than 0.05. It reads 0.039 and you breathe a sigh of relief. Without that P-value, you would have been stuck with your null hypothesis—that terrible possibility that your observed effect was meaningless. Instead, with the P-value on your side, you're finally ready to publish a significant observation. That is, unless you show it to Valen Johnson, a statistics professor at Texas A&M University, who has just published an analysis in PNAS1 that indicates your data are not so convincing.
Tina W. Han, a postdoctoral fellow at the University of California, San Francisco (UCSF), who did her graduate work at the University of Texas Southwestern Medical Center (UT Southwestern), has been named the winner of the first $5,000 ASCB Kaluza Prize supported by Beckman Coulter for outstanding research by a graduate student. Han won for her breakthrough work on the functional characterization of RNA granules while in Steven McKnight's lab at UT Southwestern. Nine additional Kaluza entrants were named winners of ASCB Beckman Coulter Distinguished Graduate Student Achievement Prizes, which will include travel awards to attend the 2014 ASCB Annual Meeting in Philadelphia.
Remember that second-grade science project when you watched bean plants grow toward a light source? Little did you know, you were researching heliotropism. Tropism in plants is turning toward or away from a stimulus such as sunlight, gravity, or water. And now there's a new tropism to investigate, although not for second graders.
It's hard to imagine a scientific conference without poster presentations. There would be tumbleweeds rolling through the exhibit hall, company reps would be asleep in their booths, and grad student and postdocs would be hung-over every morning of the meeting.
It's been nearly a year since an insurgent group of scientists and journal editors gathered in San Francisco at the ASCB Annual Meeting to plot a counterattack on the outsized influence of "impact factor" on scientific assessment. A metric invented in the 1960s by Eugene Garfield to help academic librarians subscribe to influential journals, the journal impact factor had become a misleading measure, the insurgents agreed. In June, they issued the Declaration on Research Assessment (DORA), asking the world science community to sign on, endorsing 18 recommendations for new standards of research assessment that would move away from journal-based metrics to individual assessment. The number of DORA signatories is now approaching 10,000. Evidently, scientists are ready for something better than the impact factor, but what?
It was in San Diego and nearly 40 years ago but Randy Schekman still vividly remembers his first ASCB Annual Meeting. George Palade, fresh from Stockholm where he had just received his 1974 Nobel Prize in Physiology or Medicine, was there to speak about the innovations in electron microscopy and cell fractionation that earned him the prize. Schekman has no better word for the experience than "thrilling."